Filing Analysis
Regulation FD Disclosure
Filed Mar 24, 2026
LOW
Sanara MedTech Inc. announced its financial results for the fourth quarter and full year ended December 31, 2025. The results were disclosed via a press release furnished as an exhibit to the 8-K filing on March 24, 2026.
Key Facts
- Reporting date of March 24, 2026, for the fiscal period ended December 31, 2025.
- The filing was made under Item 2.02 (Results of Operations and Financial Condition).
- Exhibit 99.1 contains the press release detailing the financial performance.
Regulation FD Disclosure
Filed Mar 02, 2026
LOW
Sanara MedTech Inc. furnished an investor presentation in connection with its participation in the TD Cowen 46th Annual Health Care Conference. The presentation outlines the company's strategic priorities and provides anticipated revenue guidance for the 2026 fiscal year.
Key Facts
- The company is presenting at the TD Cowen 46th Annual Health Care Conference in Boston on March 3, 2026.
- The filing includes an investor presentation as Exhibit 99.1.
- The presentation contains anticipated revenue figures for the 2026 fiscal year.
- The information is furnished under Item 7.01 and is not deemed 'filed' for purposes of Section 18 of the Exchange Act.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.